½ÃÀ庸°í¼­
»óǰÄÚµå
1460734

¼¼°èÀÇ ¹ÙÀÌ¿À Ã˸нÃÀå : ½ÃÀå ±Ô¸ð ¹× Á¡À¯À² ºÐ¼®(¿ø·áº°, Á¾·ùº°, ¿ëµµº°) - »ê¾÷ ¼ö¿ä ¿¹Ãø(-2030³â)

Biocatalyst Market Size and Share Analysis by Source, Type, Application - Global Industry Demand Forecast to 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Prescient & Strategic Intelligence | ÆäÀÌÁö Á¤º¸: ¿µ¹® 240 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

½ÃÀå °³¿ä

¼¼°è ¹ÙÀÌ¿À Ã˸нÃÀå ±Ô¸ð´Â 2023³â 6¾ï 760¸¸ ´Þ·¯·Î 2024³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 6.3% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 9¾ï 2,520¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

»ý¹° À¯·¡ ¹ÙÀÌ¿À Ã˸Ŵ °¢Á¾ »ê¾÷ ºÐ¾ß¿¡¼­ ÀϹÝÀûÀ¸·Î ¼®À¯ À¯·¡ ÇÕ¼º Ã˸Ÿ¦ ´ëüÇÒ ¼ö Àִ ģȯ°æ Ã˸ÅÀÔ´Ï´Ù. Ư¼ö È­ÇÐÁ¦Ç°°ú ¹ü¿ë È­ÇÐÁ¦Ç° »ý»ê¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.

»ý¹°Ã˸ÅÀÇ °¡Àå µÎµå·¯Áø »ê¾÷Àû ÀÀ¿ëÀº ÀǾàǰÀÇ Çâ°ú Çâ·á¿¡ »ç¿ëµÇ´Â ÀÔüƯÀÌÀû È­ÇÕ¹°(۶ö È­ÇÕ¹°À̶ó°íµµ ÇÔ)ÀÔ´Ï´Ù. ۶ö¼º ¼ö»ê±â¸¦ °¡Áø Áß°£ È­ÇÕ¹°Àº ÀǾàǰ¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ È­ÇÐÁ¦Ç°ÀÇ Á¦Á¶¿¡ »ç¿ëµÉ »Ó¸¸ ¾Æ´Ï¶ó ´Ù¾çÇÑ ¿ø·á ÀǾàǰ¿¡µµ Á¸ÀçÇÕ´Ï´Ù.

ÁÖ¿ä ÀλçÀÌÆ®

À¯Çüº°·Î º¸¸é 2023³â ÇÏÀ̵å·Ñ¶óÁ¦´Â ¸®ÆÄ¾ÆÁ¦, ¾Æ¹Ð¶ó¾ÆÁ¦, ÇÁ·ÎÅ×¾ÆÁ¦ µî ´Ù¾çÇÑ »ý¹°ÇÐÀû ÀýÂ÷¿¡ ÇʼöÀûÀÎ È¿¼Ò·Î¼­ ¾÷°è ¸ÅÃâÀÇ 40%¸¦ Â÷ÁöÇß½À´Ï´Ù.

¿ëµµº°·Î´Â 2023³â ½ÄÀ½·á Ä«Å×°í¸®°¡ 25%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

¿ø·áº°·Î´Â ¹Ì»ý¹°ÀÌ 2023³â 2¾ï ´Þ·¯ÀÇ ¸ÅÃâÀ» ±â·ÏÇßÀ¸¸ç, °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù.

Áö¿ªº°·Î º¸¸é 2023³â¿¡´Â ºÏ¹Ì Áö¿ªÀÌ ¸ÅÃâ ±âÁØ ÃÖ´ë Áö¿ªÀ¸·Î ºÎ»óÇϸç Å« ÆøÀÇ ¹ßÀü ±Ëµµ¸¦ À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°èÀÇ ¹ÙÀÌ¿À Ã˸нÃÀå¿¡ ´ëÇØ ºÐ¼®ÇßÀ¸¸ç, ½ÃÀåÀÇ ±âº» ±¸Á¶¿Í ÃֽŠ»óȲ, ÁÖ¿ä ÃËÁø¡¤¾ïÁ¦¿äÀÎ, ¼¼°è Àüü ¹× Áö¿ªº°¡¤ÁÖ¿ä ±¹°¡º° ½ÃÀå ±Ô¸ð µ¿Çâ Àü¸Á(¼ö·®¡¤±Ý¾× ±âÁØ, 2017-2030³â), ¿ø·áº°¡¤À¯Çüº°¡¤¿ëµµº° »ó¼¼ µ¿Çâ, ÇöÀç ½ÃÀå °æÀï »óȲ, ÁÖ¿ä ±â¾÷ °³¿ä µîÀ» Á¶»çÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹üÀ§

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå ÁöÇ¥

Á¦5Àå ¾÷°è Àü¸Á

  • ½ÃÀå ¿ªÇÐ
    • µ¿Çâ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ/°úÁ¦
    • ¼ºÀå ÃËÁø¿äÀÎ/¾ïÁ¦¿äÀÎÀÇ ¿µÇ⠺м®
  • ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19)ÀÇ ¿µÇâ
  • Porter's Five Forces ºÐ¼®

Á¦6Àå ¼¼°è ½ÃÀå

  • °³¿ä
  • ½ÃÀå ±Ô¸ð : ¿ø·áº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : ¿ø·áº°(2017-2030³â)
  • ½ÃÀå ±Ô¸ð : Á¾·ùº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : Á¾·ùº°(2017-2030³â)
  • ½ÃÀå ±Ô¸ð : ¿ëµµº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : ¿ëµµº°(2017-2030³â)
  • ½ÃÀå ±Ô¸ð : Áö¿ªº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : Áö¿ªº°(2017-2030³â)

Á¦7Àå ºÏ¹Ì ½ÃÀå

  • °³¿ä
  • ½ÃÀå ±Ô¸ð : ¿ø·áº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : ¿ø·áº°(2017-2030³â)
  • ½ÃÀå ±Ô¸ð : Á¾·ùº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : Á¾·ùº°(2017-2030³â)
  • ½ÃÀå ±Ô¸ð : ¿ëµµº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : ¿ëµµº°(2017-2030³â)
  • ½ÃÀå ±Ô¸ð : Áö¿ªº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : Áö¿ªº°(2017-2030³â)

Á¦8Àå À¯·´ ½ÃÀå

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦10Àå ¶óÆ¾¾Æ¸Þ¸®Ä« ½ÃÀå

Á¦11Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦12Àå ¹Ì±¹ ½ÃÀå

  • °³¿ä
  • ½ÃÀå ±Ô¸ð : ¿ø·áº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : ¿ø·áº°(2017-2030³â)
  • ½ÃÀå ±Ô¸ð : Á¾·ùº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : Á¾·ùº°(2017-2030³â)
  • ½ÃÀå ±Ô¸ð : ¿ëµµº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : ¿ëµµº°(2017-2030³â)

Á¦13Àå ij³ª´Ù ½ÃÀå

Á¦14Àå µ¶ÀÏ ½ÃÀå

Á¦15Àå ÇÁ¶û½º ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦18Àå ½ºÆäÀÎ ½ÃÀå

Á¦19Àå ÀϺ» ½ÃÀå

Á¦20Àå Áß±¹ ½ÃÀå

Á¦21Àå Àεµ ½ÃÀå

Á¦22Àå È£ÁÖ ½ÃÀå

Á¦23Àå Çѱ¹ ½ÃÀå

Á¦24Àå ºê¶óÁú ½ÃÀå

Á¦25Àå ¸ß½ÃÄÚ ½ÃÀå

Á¦26Àå »ç¿ìµð¾Æ¶óºñ¾Æ ½ÃÀå

Á¦27Àå ³²¾ÆÇÁ¸®Ä«°øÈ­±¹ ½ÃÀå

Á¦28Àå ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE) ½ÃÀå

Á¦29Àå °æÀï »óȲ

  • ½ÃÀå ÁøÃâ ±â¾÷°ú ±× Á¦°ø Á¦Ç°/¼­ºñ½º ¸®½ºÆ®
  • ÁÖ¿ä ±â¾÷ °æÀï º¥Ä¡¸¶Å©
  • ÁÖ¿ä ±â¾÷ÀÇ Á¦Ç° º¥Ä¡¸¶Å©
  • ÃÖ±ÙÀÇ Àü·« Àü°³ »óȲ

Á¦30Àå ±â¾÷ °³¿ä

  • Codexis Inc.
  • DuPont de Nemours Inc.
  • Koninklijke DSM N.V.
  • Novozymes
  • BASF SE
  • Amano Enzyme Inc.
  • Biocatalysts Limited
  • AB Enzymes GmbH
  • Lonza Group Ltd.
  • Chr. Hansen Holding A/S

Á¦31Àå ºÎ·Ï

ksm 24.04.22

Market Overview

In 2023, the biocatalyst market was valued at USD 607.6 million and is projected to grow at a CAGR of 6.3% from 2024 to 2030, reaching USD 925.2 million by 2030.

Biocatalysts sourced from biological origins offer an eco-friendly substitute for synthetic catalysts, commonly derived from petroleum, across various industrial sectors. They play a significant role in producing both specialty and commodity chemicals.

The advancement of cost-effective genetic engineering techniques has significantly contributed to their increased manufacturing. These bio-enzymes enable precise reactions, leading to desired outcomes with minimal waste and fewer by-products, bolstering their appeal in industrial processes.

Biocatalysts are progressively becoming functional in biotransformation procedures, and therefore, they have become significant nearly in all industries, mainly chemicals, and pharmaceuticals. The growth of lucrative and ecological chemoenzymatic processes strongly relies on the extensive accessibility and pertinency of enzymes with high performance, irrespective of ecological conditions.

Biocatalysis guarantees that compound molecules are made with high accuracy while meeting severe quality standards. This adhesive their cruciality in the pharmacological sector, where accurate quality and concentrations are important.

The most prominent industrial applications of biocatalysis are stereospecific compounds (also called chiral compounds) used for pharmaceuticals aromas and fragrances. Chiral hydroxyl moieties medium compounds exist in various APIs as well as they are used in the production of various chemicals for use in pharmaceuticals.

Key Insights

In 2023, hydrolases held 40% of the industry revenue, essential in diverse biological procedures such as lipases, amidases, and proteases.

Hydrolases feature prominently in permitted medications for conditions such as Alzheimer's, diabetes, and communicable diseases.

These enzymes are also used in detergent formulations to eliminate blood and protein stains, guaranteeing clean clothes.

In 2023, the food & beverages category had a 25% revenue share among biocatalyst applications.

Biocatalysts are vital enzymes in food processing and additive production.

Sectors such as brewing, bakery, dairy, meat, beverages, and sugar use bio-enzymes widely.

Biocatalysis is favored because of growing ecological awareness and sustainability requirements, providing advanced effectiveness and safety.

Its sustainability stems from working under mild conditions and decreasing energy use, waste, and by-products.

Constant innovation permits biocatalysis to evolve and fulfill diverse market requirements efficiently.

In 2023, microorganisms contributed USD 0.2 billion to the industry, and the category is projected to showcase significant growth.

Enzymes from microbial sources are lucrative, scalable for wholesale production, and have high enzyme content.

Microbe-based enzymes are strong, quicken reactions efficiently, produce diverse compounds, and provide cost benefits.

In 2023, the North American region arose as the largest revenue contributor to the worldwide biocatalyst industry and is projected to uphold a substantial development trajectory.

This development is mainly propelled by the strong pharmaceutical and food sectors dominant in the region, which cater as major industry drivers.

The United States and Europe comprise the two leading superpowers of the world pharmaceutical industry, with America capturing 49.1% of the market and Europe controlling 23.4% of the global turnover of pharmaceuticals in 2021.

Statics from the European Federation of Pharmaceutical Industries and Associations (EFPIA) reveal the contribution of the United States and Europe was 64.4% and 16.2% respectively, newly drugs launched between 2016 and 2021.

Table of Contents

Chapter 1. Research Scope

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Analysis Period
  • 1.4. Market Size Breakdown by Segments
    • 1.4.1. Market size breakdown, by source
    • 1.4.2. Market size breakdown, by type
    • 1.4.3. Market size breakdown, by application
    • 1.4.4. Market size breakdown, by region
    • 1.4.5. Market size breakdown, by country
  • 1.5. Market Data Reporting Unit
    • 1.5.1. Volume
    • 1.5.2. Value
  • 1.6. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
    • 2.1.1. Paid
    • 2.1.2. Unpaid
    • 2.1.3. P&S Intelligence database
  • 2.2. Primary Research
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Currency Conversion Rates
  • 2.6. Assumptions for the Study
  • 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

  • 5.1. Market Dynamics
    • 5.1.1. Trends
    • 5.1.2. Drivers
    • 5.1.3. Restraints/challenges
    • 5.1.4. Impact analysis of drivers/restraints
  • 5.2. Impact of COVID-19
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Bargaining power of buyers
    • 5.3.2. Bargaining power of suppliers
    • 5.3.3. Threat of new entrants
    • 5.3.4. Intensity of rivalry
    • 5.3.5. Threat of substitutes

Chapter 6. Global Market

  • 6.1. Overview
  • 6.2. Market Volume, by Source (2017-2030)
  • 6.3. Market Revenue, by Source (2017-2030)
  • 6.4. Market Volume, by Type (2017-2030)
  • 6.5. Market Revenue, by Type (2017-2030)
  • 6.6. Market Volume, by Application (2017-2030)
  • 6.7. Market Revenue, by Application (2017-2030)
  • 6.8. Market Volume, by Region (2017-2030)
  • 6.9. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

  • 7.1. Overview
  • 7.2. Market Volume, by Source (2017-2030)
  • 7.3. Market Revenue, by Source (2017-2030)
  • 7.4. Market Volume, by Type (2017-2030)
  • 7.5. Market Revenue, by Type (2017-2030)
  • 7.6. Market Volume, by Application (2017-2030)
  • 7.7. Market Revenue, by Application (2017-2030)
  • 7.8. Market Volume, by Country (2017-2030)
  • 7.9. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

  • 8.1. Overview
  • 8.2. Market Volume, by Source (2017-2030)
  • 8.3. Market Revenue, by Source (2017-2030)
  • 8.4. Market Volume, by Type (2017-2030)
  • 8.5. Market Revenue, by Type (2017-2030)
  • 8.6. Market Volume, by Application (2017-2030)
  • 8.7. Market Revenue, by Application (2017-2030)
  • 8.8. Market Volume, by Country (2017-2030)
  • 8.9. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

  • 9.1. Overview
  • 9.2. Market Volume, by Source (2017-2030)
  • 9.3. Market Revenue, by Source (2017-2030)
  • 9.4. Market Volume, by Type (2017-2030)
  • 9.5. Market Revenue, by Type (2017-2030)
  • 9.6. Market Volume, by Application (2017-2030)
  • 9.7. Market Revenue, by Application (2017-2030)
  • 9.8. Market Volume, by Country (2017-2030)
  • 9.9. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

  • 10.1. Overview
  • 10.2. Market Volume, by Source (2017-2030)
  • 10.3. Market Revenue, by Source (2017-2030)
  • 10.4. Market Volume, by Type (2017-2030)
  • 10.5. Market Revenue, by Type (2017-2030)
  • 10.6. Market Volume, by Application (2017-2030)
  • 10.7. Market Revenue, by Application (2017-2030)
  • 10.8. Market Volume, by Country (2017-2030)
  • 10.9. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

  • 11.1. Overview
  • 11.2. Market Volume, by Source (2017-2030)
  • 11.3. Market Revenue, by Source (2017-2030)
  • 11.4. Market Volume, by Type (2017-2030)
  • 11.5. Market Revenue, by Type (2017-2030)
  • 11.6. Market Volume, by Application (2017-2030)
  • 11.7. Market Revenue, by Application (2017-2030)
  • 11.8. Market Volume, by Country (2017-2030)
  • 11.9. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

  • 12.1. Overview
  • 12.2. Market Volume, by Source (2017-2030)
  • 12.3. Market Revenue, by Source (2017-2030)
  • 12.4. Market Volume, by Type (2017-2030)
  • 12.5. Market Revenue, by Type (2017-2030)
  • 12.6. Market Volume, by Application (2017-2030)
  • 12.7. Market Revenue, by Application (2017-2030)

Chapter 13. Canada Market

  • 13.1. Overview
  • 13.2. Market Volume, by Source (2017-2030)
  • 13.3. Market Revenue, by Source (2017-2030)
  • 13.4. Market Volume, by Type (2017-2030)
  • 13.5. Market Revenue, by Type (2017-2030)
  • 13.6. Market Volume, by Application (2017-2030)
  • 13.7. Market Revenue, by Application (2017-2030)

Chapter 14. Germany Market

  • 14.1. Overview
  • 14.2. Market Volume, by Source (2017-2030)
  • 14.3. Market Revenue, by Source (2017-2030)
  • 14.4. Market Volume, by Type (2017-2030)
  • 14.5. Market Revenue, by Type (2017-2030)
  • 14.6. Market Volume, by Application (2017-2030)
  • 14.7. Market Revenue, by Application (2017-2030)

Chapter 15. France Market

  • 15.1. Overview
  • 15.2. Market Volume, by Source (2017-2030)
  • 15.3. Market Revenue, by Source (2017-2030)
  • 15.4. Market Volume, by Type (2017-2030)
  • 15.5. Market Revenue, by Type (2017-2030)
  • 15.6. Market Volume, by Application (2017-2030)
  • 15.7. Market Revenue, by Application (2017-2030)

Chapter 16. U.K. Market

  • 16.1. Overview
  • 16.2. Market Volume, by Source (2017-2030)
  • 16.3. Market Revenue, by Source (2017-2030)
  • 16.4. Market Volume, by Type (2017-2030)
  • 16.5. Market Revenue, by Type (2017-2030)
  • 16.6. Market Volume, by Application (2017-2030)
  • 16.7. Market Revenue, by Application (2017-2030)

Chapter 17. Italy Market

  • 17.1. Overview
  • 17.2. Market Volume, by Source (2017-2030)
  • 17.3. Market Revenue, by Source (2017-2030)
  • 17.4. Market Volume, by Type (2017-2030)
  • 17.5. Market Revenue, by Type (2017-2030)
  • 17.6. Market Volume, by Application (2017-2030)
  • 17.7. Market Revenue, by Application (2017-2030)

Chapter 18. Spain Market

  • 18.1. Overview
  • 18.2. Market Volume, by Source (2017-2030)
  • 18.3. Market Revenue, by Source (2017-2030)
  • 18.4. Market Volume, by Type (2017-2030)
  • 18.5. Market Revenue, by Type (2017-2030)
  • 18.6. Market Volume, by Application (2017-2030)
  • 18.7. Market Revenue, by Application (2017-2030)

Chapter 19. Japan Market

  • 19.1. Overview
  • 19.2. Market Volume, by Source (2017-2030)
  • 19.3. Market Revenue, by Source (2017-2030)
  • 19.4. Market Volume, by Type (2017-2030)
  • 19.5. Market Revenue, by Type (2017-2030)
  • 19.6. Market Volume, by Application (2017-2030)
  • 19.7. Market Revenue, by Application (2017-2030)

Chapter 20. China Market

  • 20.1. Overview
  • 20.2. Market Volume, by Source (2017-2030)
  • 20.3. Market Revenue, by Source (2017-2030)
  • 20.4. Market Volume, by Type (2017-2030)
  • 20.5. Market Revenue, by Type (2017-2030)
  • 20.6. Market Volume, by Application (2017-2030)
  • 20.7. Market Revenue, by Application (2017-2030)

Chapter 21. India Market

  • 21.1. Overview
  • 21.2. Market Volume, by Source (2017-2030)
  • 21.3. Market Revenue, by Source (2017-2030)
  • 21.4. Market Volume, by Type (2017-2030)
  • 21.5. Market Revenue, by Type (2017-2030)
  • 21.6. Market Volume, by Application (2017-2030)
  • 21.7. Market Revenue, by Application (2017-2030)

Chapter 22. Australia Market

  • 22.1. Overview
  • 22.2. Market Volume, by Source (2017-2030)
  • 22.3. Market Revenue, by Source (2017-2030)
  • 22.4. Market Volume, by Type (2017-2030)
  • 22.5. Market Revenue, by Type (2017-2030)
  • 22.6. Market Volume, by Application (2017-2030)
  • 22.7. Market Revenue, by Application (2017-2030)

Chapter 23. South Korea Market

  • 23.1. Overview
  • 23.2. Market Volume, by Source (2017-2030)
  • 23.3. Market Revenue, by Source (2017-2030)
  • 23.4. Market Volume, by Type (2017-2030)
  • 23.5. Market Revenue, by Type (2017-2030)
  • 23.6. Market Volume, by Application (2017-2030)
  • 23.7. Market Revenue, by Application (2017-2030)

Chapter 24. Brazil Market

  • 24.1. Overview
  • 24.2. Market Volume, by Source (2017-2030)
  • 24.3. Market Revenue, by Source (2017-2030)
  • 24.4. Market Volume, by Type (2017-2030)
  • 24.5. Market Revenue, by Type (2017-2030)
  • 24.6. Market Volume, by Application (2017-2030)
  • 24.7. Market Revenue, by Application (2017-2030)

Chapter 25. Mexico Market

  • 25.1. Overview
  • 25.2. Market Volume, by Source (2017-2030)
  • 25.3. Market Revenue, by Source (2017-2030)
  • 25.4. Market Volume, by Type (2017-2030)
  • 25.5. Market Revenue, by Type (2017-2030)
  • 25.6. Market Volume, by Application (2017-2030)
  • 25.7. Market Revenue, by Application (2017-2030)

Chapter 26. Saudi Arabia Market

  • 26.1. Overview
  • 26.2. Market Volume, by Source (2017-2030)
  • 26.3. Market Revenue, by Source (2017-2030)
  • 26.4. Market Volume, by Type (2017-2030)
  • 26.5. Market Revenue, by Type (2017-2030)
  • 26.6. Market Volume, by Application (2017-2030)
  • 26.7. Market Revenue, by Application (2017-2030)

Chapter 27. South Africa Market

  • 27.1. Overview
  • 27.2. Market Volume, by Source (2017-2030)
  • 27.3. Market Revenue, by Source (2017-2030)
  • 27.4. Market Volume, by Type (2017-2030)
  • 27.5. Market Revenue, by Type (2017-2030)
  • 27.6. Market Volume, by Application (2017-2030)
  • 27.7. Market Revenue, by Application (2017-2030)

Chapter 28. U.A.E. Market

  • 28.1. Overview
  • 28.2. Market Volume, by Source (2017-2030)
  • 28.3. Market Revenue, by Source (2017-2030)
  • 28.4. Market Volume, by Type (2017-2030)
  • 28.5. Market Revenue, by Type (2017-2030)
  • 28.6. Market Volume, by Application (2017-2030)
  • 28.7. Market Revenue, by Application (2017-2030)

Chapter 29. Competitive Landscape

  • 29.1. List of Market Players and their Offerings
  • 29.2. Competitive Benchmarking of Key Players
  • 29.3. Product Benchmarking of Key Players
  • 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

  • 30.1. Codexis Inc.
    • 30.1.1. Business overview
    • 30.1.2. Product and service offerings
    • 30.1.3. Key financial summary
  • 30.2. DuPont de Nemours Inc.
    • 30.2.1. Business overview
    • 30.2.2. Product and service offerings
    • 30.2.3. Key financial summary
  • 30.3. Koninklijke DSM N.V.
    • 30.3.1. Business overview
    • 30.3.2. Product and service offerings
    • 30.3.3. Key financial summary
  • 30.4. Novozymes
    • 30.4.1. Business overview
    • 30.4.2. Product and service offerings
    • 30.4.3. Key financial summary
  • 30.5. BASF SE
    • 30.5.1. Business overview
    • 30.5.2. Product and service offerings
    • 30.5.3. Key financial summary
  • 30.6. Amano Enzyme Inc.
    • 30.6.1. Business overview
    • 30.6.2. Product and service offerings
    • 30.6.3. Key financial summary
  • 30.7. Biocatalysts Limited
    • 30.7.1. Business overview
    • 30.7.2. Product and service offerings
    • 30.7.3. Key financial summary
  • 30.8. AB Enzymes GmbH
    • 30.8.1. Business overview
    • 30.8.2. Product and service offerings
    • 30.8.3. Key financial summary
  • 30.9. Lonza Group Ltd.
    • 30.9.1. Business overview
    • 30.9.2. Product and service offerings
    • 30.9.3. Key financial summary
  • 30.10. Chr. Hansen Holding A/S
    • 30.10.1. Business overview
    • 30.10.2. Product and service offerings
    • 30.10.3. Key financial summary

Chapter 31. Appendix

  • 31.1. Abbreviations
  • 31.2. Sources and References
  • 31.3. Related Reports
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦